Univariate Kaplan–Meier analysis of 1145 NSCLC cases demonstrated that NSCLC patients with high COMMD4 expression had a poorer outcome than patients with lower COMMD4 expression (HR = 1.28, CI: 1.13–1.46, log rank p = 0.0001) (Fig. 1e). The gene discussed is COMMD4; the disease is non-small cell lung carcinoma.